Hypersensitivity syndrome associated with efavirenz therapy.
Bossi
P
P
Department of Infectious Diseases, Hôpital Pitié-Salpêtrière, 75651 Paris Cedex 13, France. philippe.bossi@psl.ap-hop-paris.fr
Colin
D
D
Bricaire
F
F
Caumes
E
E
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D003521:Cyclopropanes; D004342:Drug Hypersensitivity / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D013577:Syndrome
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz